Thailand's home-grown Covid-19 vaccine to start production first quarter 2022


Image from The Nation Thailand/ANN

BANGKOK, Nov 20 (Bernama): Thailand’s Chulalongkorn University is expected to start the production of its mRNA Covid-19 vaccine, ChulaCov19, in the first quarter of next year.

Head of the Covid-19 vaccine development project Dr Kiat Ruxrungtham said ChulaCov19 will enter its third phase of human trials, with jabs scheduled to be administered in the first quarter of 2022 as well.

Save 30% and win Bosch appliances! More Info

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Thailand , Covid-19 , Vaccine , ChulaCov19 , mRNA

Next In Aseanplus News

Vietnam takes action to prevent origin fraud in export
From NIMBY to YIMBY: In shrinking cities in South Korea, prisons bring hope
Two dead, 9 injured after car rams into crowd in central Philippines
Cooperation with China to boost Thailand space industry development
China-Asean economic, trade cooperation in fast lane
Tigers at dawn: The wild beauty of India's Ranthambore National Park
China and Cambodia agree on financing for a 94-mile canal linking the Mekong to the Gulf of Thailand
Russian air force plan in Indonesia draws controversy
Put some respect on Malaysia's name, MP tells O'Reilly
Chinese woman cosplaying as Lady Rocky from Ne Zha film attacked after mistaken for Japanese

Others Also Read